Skip to main content
SpringerLink
Log in

Alemtuzumab

Acquired Haemophilia A: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Pisa M, et al. First reported case of Aquired Hemophilia A (AHA) as secondary autoimmune disease following alemtuzumab treatment in multiple sclerosis. European Journal of Neurology 24 (Suppl. 1): 404, Jul 2017. Available from: URL: http://doi.org/10.1111/ene.13367 [abstract] - Italy

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alemtuzumab. Reactions Weekly 1664, 26 (2017). https://doi.org/10.1007/s40278-017-34306-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-017-34306-7

Search

Navigation